Product Information
ROPINIROLE HCL 0.25 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0456 per EA under NDC 62332003031. Its NADAC has been published 537 times since May 11, 2016.
FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003031
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090429FDA Approved
3/24/2010
TE Code
AB
On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.25 MG TABLET has been published 537 times since May 11, 2016, and over the history we have for it it has declined 54.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0456 per EA |
|---|---|
| All-time high | $0.1117 (Feb 15, 2017) |
| All-time low | $0.0347 (Nov 20, 2024) |
| 52-week high | $0.0476 |
| 52-week low | $0.0453 |
| Median price | $0.0592 |
| Average price | $0.0626 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 537 |
| Tracking since | May 11, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.25 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0456 per EA (NDC 62332003031), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has declined 54.6%. It has been tracked across 537 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.25 MG TABLET?
Since May 11, 2016, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.1117 (Feb 15, 2017), with a median of $0.0592 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 0.25 MG TABLET?
ROPINIROLE HCL 0.25 MG TABLET (NDC 62332003031) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.